36C25026N0292↗
Exelan Pharmaceuticals Inc received this contract from 250-Network Contract Office 10 (36C250), Department of Veterans Affairs: $2.62M obligated so far for drugs and biologicals. Its period of performance ended 2026-07-31.
Key facts · data as of Oct 25, 2026
- Recipient
- Exelan Pharmaceuticals Inc
- Awarding agency
- Department of Veterans Affairs
- Contracting office
- 250-Network Contract Office 10 (36C250) (36C250)
- Obligated to date
- $2.62M
- Potential value
- $2.62M
- Ends
- 2026-07-31
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 36C25026N0292, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_36C25026N0292_3600_36F79720D0227_3600
Exelan Pharmaceuticals Inc: all federal awards · Department of Veterans Affairs: spending · 250-Network Contract Office 10 (36C250): what it buys · The follow-on: recompete brief
LENALIDOMIDE
Up for re-bid: ends 2026-07-31. Recompete brief → · 6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052 ↗
What it is
- Product or service
- Drugs and Biologicals (PSC 6505)
- Industry
- Pharmaceutical Preparation Manufacturing (NAICS 325412)
- Contracting office
- 250-Network Contract Office 10 (36C250) (36C250)
- Competition
- Full and open competition · 3 offers received
- Pricing
- Firm fixed price
- How it was bought
- GSA Schedule · under 36F79720D0227
- Solicitation
- 36C25026Q0139
- Where the work is
- Palm Beach, FL · district FL-23
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
2 actions since 2026-01-27. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-06-03 | P00001 | Option exercised | $73.9K | LENALIDOMIDE |
| 2026-01-27 | 0 | $2.55M | LENALIDOMIDE |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗